AXSM vs NXH
AXSM: A biopharmaceutical company developing and commercializing innovative therapies for central nervous system disorders. NXH: Neighborhood Intelligence is a technology-focused retail and home-services ecosystem that combines an expansive e-commerce platform with home-ownership solutions and strategic blockchain investments.
Side-by-side fundamentals
| Metric | AXSM | NXH | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $170.08 | $1.72 | |
| Market cap | $8.9B | $163M | |
| Net margin | -28.7% | -18.6% | NXH higher |
| Gross margin FY2025, SEC XBRL | n/a | +24.7% | |
| Operating margin FY2025, SEC XBRL | -26.1% | -5.9% | NXH higher |
| ROE | -207.5% | -159.0% | NXH higher |
| ROA | -26.6% | -64.4% | AXSM higher |
| Debt / equity as of 2026-09-03 | 2.43 | n/a | |
| Revenue growth (YoY) as of 2026-09-03 | +56.9% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +133.7% | -18.5% | AXSM higher |
| Dividend streak (yrs) SEC XBRL | 0 | n/a | |
| Beta as of 2026-09-03 | 0.67 | 2.10 | |
| 1-year return as of 2026-10-08 close | +43.3% | -84.6% | AXSM higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.